Theratechnologies | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Theratechnologies | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Theratechnologies | 6-K: Report of foreign private issuer (related to financial reporting)
Theratechnologies | 6-K: Report of foreign private issuer (related to financial reporting)
Theratechnologies | 6-K: Report of foreign private issuer (related to financial reporting)
Theratechnologies | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Theratechnologies | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Theratechnologies | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Theratechnologies | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Theratechnologies | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Theratechnologies | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Theratechnologies | 20-F: Registration statement / Annual report / Transition report
Theratechnologies | 6-K: Report of foreign private issuer (related to financial reporting)
Theratechnologies | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Theratechnologies | SC 13G: Statement of acquisition of beneficial ownership by individuals-Nantahala Capital Management, LLC(5.8%),Wilmot B. Harkey(5.8%), etc.
Theratechnologies | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-AIGH Capital Management, LLC(8.1%),Orin H(8.1%)
Theratechnologies | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Theratechnologies | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Theratechnologies | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Theratechnologies | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
No Data